top of page
Sensirion_edited.jpg

Year:

2015

Vertical:

Health & Nutrition

Ranking:

Top 3

Inositec

Inositec AG is developing first-in-class treatments for soft tissue calcification disorders based on its proprietary Inositune™ platform of inositol phosphate (IP6) analogs. The company’s lead programs address vascular and renal calcification disorders, including orphan indications.

2000_W1_Carbofix.png
bottom of page